E.Oberdorf-MaassS
Interactions : With chemotherapy
To learn more and stay connected, follow us on Facebook, Instagram, LinkedIn, YouTube, and Pinterest.
However, the VA National Criteria for Use guidelines for checkpoint inhibitor initiation explicitly allow use only for ECOG performance status score of 0 or 1 for all immunotherapy agents, with some exceptions for ECOG performance status score of 0 to 2 for nivolumab and pembrolizumab
Of note, BPC 157 therapy markedly attenuated thrombosis both in arteries and veins, peripherally and centrally (Figure 1)
Of interest is the strict conservation of the four cysteines (Cys14, Cys47, Cys101 and Cys169) that confer peculiar redox sensitivity to this enzyme